Replacing Cardiopulmonary Bypass with Extracorporeal Membrane Oxygenation in Lung Transplantation Operations
- 1 August 2001
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 25 (8) , 607-612
- https://doi.org/10.1046/j.1525-1594.2001.025008607.x
Abstract
Cardiopulmonary bypass (CPB) is required in some lung transplantation (LTx) operations. However, it increases risks of bleeding and early graft dysfunction. We report our experiences of replacing CPB with heparin‐bound extracorporeal membrane oxygenation (ECMO) in LTx operations. If extracorporeal circulation was anticipated for the LTx operations, ECMO support was set up through the femoral venoarterial route after induction of anesthesia; then, LTx was done as usual. Five thousand units of heparin was injected intravenously during the femoral vessels cannulation, but no more was used during the first 24 h of ECMO support. If necessary, as in patients undergoing single LTx for end‐stage pulmonary hypertension, the ECMO support was directly extended into the postoperative period until reperfusion edema of the graft lung subsided. Twelve single LTxs and 3 bilateral sequential single LTxs were done under ECMO support. The advantages of using femoral ECMO rather than conventional CPB in LTx operations were the operative field was not disturbed by the bypass cannula, stable cardiopulmonary function and normothermia were maintained throughout the operations, there were less blood loss and transfusion requirements, and the left LTx was as easily performed as the right LTx. Red blood cell transfusion requirements during the operation and the first postoperative day were 4.4 ± 2.8 and 2.4 ± 2.0 U, respectively, in 10 adult patients undergoing uncomplicated single LTx with ECMO support, and 4.3 ± 1.3 and 1.5 ± 1.5 U in 8 adult patients undergoing single LTx without any extracorporeal circulatory support. The difference was not significant between the 2 groups (p = 0.53 and 0.32 by Mann‐Whitney U test). The ECMO did not increase blood transfusion requirements. In comparison, 13 U of red blood cell transfusion was required in 2 patients receiving single LTx under CPB support. The ECMO support made the postoperative critical care easier in recipients with graft lung edema. Except for 2 cases of primary graft failure, the ECMO could be weaned off and removed at bedside within a short period (27.9 ± 24.6 h, n = 13) with no major complications. In conclusion, the heparin‐bound femoral ECMO rather than CPB should be used for LTx operations unless concomitant cardiac repair is planned.Keywords
This publication has 16 references indexed in Scilit:
- Segmental Necrosis of Small Bronchi after Prolonged Intakes of Sauropus androgynus in TaiwanAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Single Lung Transplantation for Pulmonary HypertensionCirculation, 1995
- Single Lung Transplantation for Pulmonary LymphangiomyomatosisChest, 1995
- Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adultsThe Annals of Thoracic Surgery, 1994
- Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantationThe Annals of Thoracic Surgery, 1994
- A Decade of Lung TransplantationAnnals of Surgery, 1993
- Femoral veno-arterial extracorporcal life support with minimal or no heparinThe Annals of Thoracic Surgery, 1993
- Predictive criteria for the need of extracorporeal circulation in single-lung transplantationThe Annals of Thoracic Surgery, 1992
- PRIMARY GRAFT FAILURE FOLLOWING PULMONARY TRANSPLANTATIONTransplantation, 1990
- Heart-Lung Transplantation for Irreversible Pulmonary HypertensionThe Annals of Thoracic Surgery, 1984